|
KMID : 0366220090440020092
|
|
Korean Journal of Hematology
2009 Volume.44 No. 2 p.92 ~ p.99
|
|
|
Difference in Viability of CD34+ Cells in Cryopreserved Cord Blood According to Evaluation Methods
|
|
Ahn Mi-Sun
Lee Hyun-Woo
Kang Seok-Yun
Park Joon-Seong
Choi Jin-Hyuk
Kim Hugh-Chul
Jeong Seong-Hyun
Em Young-Woo
Yang Mal-Suk
Kim Hyo-Eun
Jang In-Keun
Lee Jong-Eun
Kim Young-Jin
|
|
|
Abstract
|
|
|
Background: On performing umbilical cord blood (UCB) transplantation, faster engraftment may lead better clinical outcome. Because transplanted viable cell count in UCB is related to the engraftment, accurate evaluation of viability of CD34+ cells in cryopreserved UCB has clinical implication. We examined the difference in viability of cells in cryopreserved UCB according to the duration of cryopreservation and different methods.
Methods: A total of 60 UCB samples which were cryopreserved for 1 to 4 years were used in this study. Viability of cryopreserved cells were examined with trypan blue exclusion assay, DNA contents analysis, caspase-3 activation test, intracellular esterase activity and Annexin-V/PI staining.
Results: After thawing the cryopreserved UCB, 89% of the total MNCs and 84% of CD34+ cells were viable as identified by trypan blue exclusion assay. In the CD34+ cell population, the cell death rate was found to be 47% by Annexin-V/PI staining and less than 5% by DNA contents analysis. However, cspase-3 activity failed to document apoptosis. The intracellular esterase activity test also showed a cell death rate of about 10∼20% at 2, 4, and 6 hours after thawing.
Conclusion: Viable cells in UCB should be measured by several compensatory techniques rather than a single method. Discordance among Annexin-V/PI staining versus trypan blue exclusion, DNA contents analysis, and the caspase-3 activation test or intracellular esterase activity should be clarified in order to apply these techniques for actual cord blood transplantation. (Korean J Hematol 2009;44:92-99.)
|
|
|
KEYWORD
|
|
|
Umbilical cord blood, Apoptosis, Viability
|
|
|
FullTexts / Linksout information
|
|
  
|
|
|
Listed journal information
|
|
  
|
|